Koers Rejuvel Bio-Sciences, Inc. Other OTC
Aandelen
NUUU
US7594081074
Overige speciaalzaken
Omzet 2013 | 0,05 0,05 | Omzet 2014 | 0,09 0,09 | Marktkapitalisatie | 35,47 mln. 33,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 * | - |
Nettoschuld 2013 | 508K 476K | Nettoschuld 2014 | 388K 363K | EV/omzet 2014 | 381.073.627 x |
K/w-verhouding 2013 * |
-
| K/w-verhouding 2014 |
-190
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 31,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 79 | 14-10-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 79 | 14-10-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,17% | 28,52 mld. | |
-19,13% | 4,04 mld. | |
+5,49% | 3,93 mld. | |
-10,01% | 1,69 mld. | |
-2,61% | 1,64 mld. | |
-15,27% | 1,26 mld. | |
-19,35% | 1,08 mld. | |
-41,24% | 769 mln. | |
+0,35% | 650 mln. |